Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathway

Jason T Huse; Matija Snuderl; David TW Jones; Carole D Brathwaite; Nolan Altman; Ehud Lavi; Richard Saffery; Alexandra Sexton-Oates; Ingmar Blumcke; David Capper; Matthias A Karajannis; Ryma Benayed; Lukas Chavez; Cheddhi Thomas; Jonathan Serrano; Laetitia Borsu; Marc Ladanyi; Marc K Rosenblum

Journal article

Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathway

Jason T Huse, Matija Snuderl, David TW Jones, Carole D Brathwaite, Nolan Altman, Ehud Lavi, Richard Saffery, Alexandra Sexton-Oates, Ingmar Blumcke, David Capper, Matthias A Karajannis, Ryma Benayed, Lukas Chavez, Cheddhi Thomas, Jonathan Serrano, Laetitia Borsu, Marc Ladanyi, Marc K Rosenblum

Acta Neuropathologica | SPRINGER | Published : 2017

DOI: 10.1007/s00401-016-1639-9

University of Melbourne Researchers

Richard Saffery Author Paediatrics Royal Children's Hospital

Grants

Awarded by National Institutes of Health

Funding Acknowledgements

This study was supported by the Friedberg Charitable Foundation (M. A. K. and M. S.) and the National Institutes of Health (P30-CA008748). The MSKCC clinical Sequenom facility was supported by the Anbinder Fund. We thank Julie Intrieri for assistance with Sequenom assays. J. T. H. is supported by a Sontag Foundation Distinguished Scientist Award.